SARENIN Drug Patent Profile
✉ Email this page to a colleague
When do Sarenin patents expire, and what generic alternatives are available?
Sarenin is a drug marketed by Procter And Gamble and is included in one NDA.
The generic ingredient in SARENIN is saralasin acetate. Additional details are available on the saralasin acetate profile page.
Summary for SARENIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 10 |
Patent Applications: | 284 |
DailyMed Link: | SARENIN at DailyMed |
US Patents and Regulatory Information for SARENIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SARENIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SARENIN
See the table below for patents covering SARENIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 333986 | ⤷ Try a Trial | |
Finland | 53305 | ⤷ Try a Trial | |
France | 2125248 | ⤷ Try a Trial | |
Philippines | 17092 | NOVEL HEPTA AND OCTAPEPTIDES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |